Scarab Genomics
Pre-clinicalKey components of conjugate vaccines, carrier proteins enhance immunogenicity of weak carbohydrate target antigens.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $1.7M
About
Key components of conjugate vaccines, carrier proteins enhance immunogenicity of weak carbohydrate target antigens.
Genetics & GenomicsSynthetic Biology
Funding History
2Total raised:$1.7M
Seed$1.2MJun 15, 2007
Grant$500KJun 15, 2005